NCT05713006
- Conditions
- ALK Gene Mutation, Bronchial Neoplasms, Carcinoma, Bronchogenic, +9 more
- Locations
-
- Thoracic Oncology Unit and Personalized Medicine Laboratory, Instituto Nacional de Cancerología Mexico City, Mexico
Clinical trial condition
Non-Small Cell Lung Cancer Stage IIIB
Explore clinical trials studying Non-Small Cell Lung Cancer Stage IIIB. Study availability and eligibility vary by location and protocol.
8 public trials
2 recruiting studies
Non-Small Cell Lung Cancer Stage IIIB trial results
NCT07428044
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +11 more
- Locations
-
- University of Michigan (Data Collection Only) Ann Arbor, Michigan, United States
- Mayo Clinic (Data Collection Only) Rochester, Minnesota, United States
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
- Memorial Sloan Kettering Monmouth (Limited Protocol Activities) Middletown, New Jersey, United States
Not Yet Recruiting
Xingbai Ji Formula Combined with Chemotherapy and Sintilimab in Metastatic Multi-Target Mutation-Negative Non-Small Cell Lung Cancer: a Clinical Trial
NCT06848426
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +12 more
- Locations
-
- Jiangxi Provincial People's Hospital Nanchang, Jiangxi, China
Completed
Combination of Osimertinib and Aspirin to Treat 1st Generation EGFR-TKI Resistance in NSCLC
NCT03543683
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +10 more
- Locations
-
- Daping Hospital Chongqing, Chongqing Municipality, China
Completed
Maintenance Low Dose Oral Navelbine In Patients With Non Small Cell Lung Cancer - MA.NI.LA Trial
NCT02176369
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
- Locations
-
- Ospedale di Gesù Fatebenefratelli Benevento, BN, Italy
- ASL Brindisi - Stabilimento Ospedaliero Di Summa-Perrino Brindisi, BR, Italy
- ASP di Bolzano - Comprensorio sanitario di Bolzano Bolzano, BZ, Italy
- Ospedale Civile SS. Annunziata Chieti, CH, Italy
NCT01473563
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +10 more
- Locations
-
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Linköping, Sweden
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Solna, Sweden
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Birmingham, United Kingdom
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. London, Greater London, United Kingdom
Active, Not Recruiting
Ceritinib Plus Docetaxel in ALK-Negative, EGFR WT Advanced NSCLC
NCT03611738
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +13 more
- Locations
-
- Advent Health Orlando Orlando, Florida, United States
- H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States
Active, Not Recruiting
Clinical Study of Neoadjuvant Chemotherapy and Immunotherapy Combined With Probiotics in Patients With Resectable NSCLC
NCT04699721
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +10 more
- Locations
-
- Xiangya Hospital of Central South University Changsha, Hunan, China